Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus R Meyer

Showing results (31-40 of 261) with videos related to

Pageof 27
Sort By:
Toxicology Letters|June 21, 2016
What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?Lea Wagmann, Markus R Meyer, Hans H Maurer
Journal of Chromatography. A|September 28, 2017
An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2Lea Wagmann, Hans H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|May 17, 2014
Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktailJulia Dinger, Markus R Meyer, Hans H Maurer
Archives of Toxicology|August 8, 2018
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuseLea Wagmann, Hans H Maurer, Markus R Meyer
Journal of Mass Spectrometry : JMS|February 5, 2013
Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MSMarkus R Meyer, Sara Schmitt, Hans H Maurer
Toxicology Letters|August 12, 2014
Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuseJulia Dinger, Markus R Meyer, Hans H Maurer
Drug Testing and Analysis|September 7, 2021
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometryAline C Vollmer, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis|November 28, 2018
Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomicsSascha K Manier, Andreas Keller, Markus R Meyer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Toxicology Letters|July 7, 2009
Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Pageof 27

Showing results (31-40 of 261) with videos related to

Sort By:
Pageof 27
Toxicology Letters|June 21, 2016
What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?Lea Wagmann, Markus R Meyer, Hans H Maurer
Journal of Chromatography. A|September 28, 2017
An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2Lea Wagmann, Hans H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|May 17, 2014
Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktailJulia Dinger, Markus R Meyer, Hans H Maurer
Archives of Toxicology|August 8, 2018
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuseLea Wagmann, Hans H Maurer, Markus R Meyer
Journal of Mass Spectrometry : JMS|February 5, 2013
Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MSMarkus R Meyer, Sara Schmitt, Hans H Maurer
Toxicology Letters|August 12, 2014
Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuseJulia Dinger, Markus R Meyer, Hans H Maurer
Drug Testing and Analysis|September 7, 2021
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometryAline C Vollmer, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis|November 28, 2018
Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomicsSascha K Manier, Andreas Keller, Markus R Meyer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Toxicology Letters|July 7, 2009
Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Pageof 27